Estrogen and peptide YY are associated with bone mineral density in premenopausal exercising women

Bone

Volumn 49, Issue 2, 2011, Pages 194-201

  Scheid, J L ^a   Toombs, R J ^a   Ducher, G ^a   Gibbs, J C ^a   Williams, N I ^a   De Souza, M J ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Bone mineral density; Estrogen; Exercise; Peptide YY; Women

Indexed keywords

ESTROGEN; ESTRONE 1 GLUCURONIDE; GLUCURONIDE; LEPTIN; PEPTIDE YY; UNCLASSIFIED DRUG;

ADULT; AMENORRHEA; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; BODY WEIGHT; BONE DENSITY; CONTROLLED STUDY; CORRELATIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN BLOOD LEVEL; EXERCISE; FEMALE; HIP; HUMAN; HUMAN EXPERIMENT; LUMBAR SPINE; METABOLITE; NORMAL HUMAN; OXYGEN CONSUMPTION; PEPTIDE ANALYSIS; PREMENOPAUSE; URINE LEVEL;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ADULT; AMENORRHEA; BONE DENSITY; ESTROGENS; ESTRONE; EXERCISE; FASTING; FEMALE; HUMANS; LEPTIN; PEPTIDE YY; PREGNANEDIOL; PREMENOPAUSE; YOUNG ADULT;

EID: 79958772061     PISSN: 87563282     EISSN: 87563282     Source Type: Journal    
DOI: 10.1016/j.bone.2011.04.011     Document Type: Article

References (50)

1. De Souza M.J., Toombs R.J., Scheid J.L., O'Donnell E., West S.L., Williams N.I. High prevalence of subtle and severe menstrual disturbances in exercising women: confirmation using daily hormone measures. Hum Reprod 2010, 25(2):491-503.
2. De Souza M.J., Miller B.E., Loucks A.B., Luciano A.A., Pescatello L.S., Campbell C.G., et al. High frequency of luteal phase deficiency and anovulation in recreational women runners: blunted elevation in follicle-stimulating hormone observed during luteal-follicular transition. J Clin Endocrinol Metab 1998, 83(12):4220-4232.
3. De Souza M.J., Williams N.I. Physiological aspects and clinical sequelae of energy deficiency and hypoestrogenism in exercising women. Hum Reprod Update 2004, 10(5):433-448.
4. Williams N.I. Lessons from experimental disruptions of the menstrual cycle in humans and monkeys. Med Sci Sports Exerc 2003, 35(9):1564.
5. De Souza M.J., Lee D.K., VanHeest J.L., Scheid J.L., West S.L., Williams N.I. Severity of energy-related menstrual disturbances increases in proportion to indices of energy conservation in exercising women. Fertil Steril 2007, 88(4):971-975.
6. De Souza M.J. Menstrual disturbances in athletes: a focus on luteal phase defects. Med Sci Sports Exerc 2003, 35(9):1553.
7. Kaufman B.A., Warren M.P., Dominguez J.E., Wang J., Heymsfield S.B., Pierson R.N. Bone density and amenorrhea in ballet dancers are related to a decreased resting metabolic rate and lower leptin levels. J Clin Endocrinol Metab 2002, 87(6):2777-2783.
8. De Souza M.J., Leidy H.J., O'Donnell E., Lasley B., Williams N.I. Fasting ghrelin levels in physically active women: relationship with menstrual disturbances and metabolic hormones. J Clin Endocrinol Metab 2004, 89(7):3536-3542.
9. Laughlin G.A., Yen S.S. Hypoleptinemia in women athletes: absence of a diurnal rhythm with amenorrhea. J Clin Endocrinol Metab 1997, 82(1):318-321.
10. Waters D.L., Qualls C.R., Dorin R., Veldhuis J.D., Baumgartner R.N. Increased pulsatility, process irregularity, and nocturnal trough concentrations of growth hormone in amenorrheic compared to eumenorrheic athletes. J Clin Endocrinol Metab 2001, 86(3):1013-1019.
11. Christo K., Cord J., Mendes N., Miller K.K., Goldstein M.A., Klibanski A., et al. Acylated ghrelin and leptin in adolescent athletes with amenorrhea, eumenorrheic athletes and controls: a cross-sectional study. Clin Endocrinol (Oxf) 2008, 69(4):628-633.
12. Schneider L.F., Monaco S.E., Warren M.P. Elevated ghrelin level in women of normal weight with amenorrhea is related to disordered eating. Fertil Steril 2008, 90(1):121-128.
13. Suh B.Y., Liu J.H., Berga S.L., Quigley M.E., Laughlin G.A., Yen S.S. Hypercortisolism in patients with functional hypothalamic-amenorrhea. J Clin Endocrinol Metab 1988, 66(4):733-739.
14. Nattiv A., Loucks A.B., Manore M.M., Sanborn C.F., Sundgot-Borgen J., Warren M.P. American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc 2007, 39(10):1867-1882.
15. Scheid J.L., Williams N.I., West S.L., VanHeest J.L., De Souza M.J. Elevated PYY is associated with energy deficiency and indices of subclinical disordered eating in exercising women with hypothalamic amenorrhea. Appetite 2009, 52(1):184-192.
16. Misra M., Miller K.K., Tsai P., Gallagher K., Lin A., Lee N., et al. Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2006, 91(3):1027-1033.
17. Pfluger P.T., Kampe J., Castaneda T.R., Vahl T., D'Alessio D.A., Kruthaupt T., et al. Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36. J Clin Endocrinol Metab 2007, 92(2):583-588.
18. Nakahara T., Kojima S., Tanaka M., Yasuhara D., Harada T., Sagiyama K., et al. Incomplete restoration of the secretion of ghrelin and PYY compared to insulin after food ingestion following weight gain in anorexia nervosa. J Psychiatr Res 2007, 41(10):814-820.
19. Batterham R.L., Cohen M.A., Ellis S.M., Le Roux C.W., Withers D.J., Frost G.S., et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 2003, 349(10):941-948.
20. Huda M.S., Wilding J.P., Pinkney J.H. Gut peptides and the regulation of appetite. Obes Rev 2006, 7(2):163-182.
21. Adrian T.E., Ferri G.L., Bacarese-Hamilton A.J., Fuessl H.S., Polak J.M., Bloom S.R. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985, 89(5):1070-1077.
22. Kim B.J., Carlson O.D., Jang H.J., Elahi D., Berry C., Egan J.M. Peptide YY is secreted after oral glucose administration in a gender-specific manner. J Clin Endocrinol Metab 2005, 90(12):6665-6671.
23. Russell M., Stark J., Nayak S., Miller K.K., Herzog D.B., Klibanski A., et al. Peptide YY in adolescent athletes with amenorrhea, eumenorrheic athletes and non-athletic controls. Bone 2009, 45(1):104-109.
24. Cobb K.l., Bachrach L.K., Greendale G., Marcus R., Neer R., Nieves J., et al. Disordered eating, menstrual irregularity, and bone mineral density in female runners. Med Sci Sports Exerc 2003, 35(5):711-719.
25. Utz A.L., Lawson E.A., Misra M., Mickley D., Gleysteen S., Herzog D.B., et al. Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone 2008, 43(1):135-139.
26. De Souza M.J., West S.l., Jamal S.A., Hawker G.A., Gundberg C.M., Williams N.I. The presence of both an energy deficiency and estrogen deficiency exacerbate alterations of bone metabolism in exercising women. Bone 2008, 43(1):140-148.
27. Drinkwater B.L., Nilson K., Chesnut C.H., Bremner W.J., Shainholtz S., Southworth M.B. Bone mineral content of amenorrheic and eumenorrheic athletes. N Engl J Med 1984, 311(5):277-281.
28. Salisbury J.J., Mitchell J.E. Bone mineral density and anorexia nervosa in women. Am J Psychiatry 1991, 148(6):768-774.
29. Misra M., Miller K.K., Stewart V., Hunter E., Kuo K., Herzog D.B., et al. Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol Metab 2005, 90(9):5082.
30. Misra M., Miller K.K., Cord J., Prabhakaran R., Herzog D.B., Goldstein M., et al. Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J Clin Endocrinol Metab 2007, 92(6):2046-2052.
31. Santoro N., Crawford S.L., Allsworth J.E., Gold E.B., Greendale G.A., Korenman S., et al. Assessing menstrual cycles with urinary hormone assays. Am J Physiol Endocrinol Metab 2003, 284(3):E521-E530.
32. Kesner J.S., Wright D.M., Schrader S.M., Chin N.W., Krieg E.F. Methods of monitoring menstrual function in field studies: efficacy of methods. Reprod Toxicol (Elmsford, NY) 1992, 6(5):385-400.
33. Rosner W., Auchus R.J., Azziz R., Sluss P.M., Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007, 92(2):405-413.
34. Stener-Victorin E., Holm G., Labrie F., Nilsson L., Janson P.O., Ohlsson C. Are there any sensitive and specific sex steroid markers for polycystic ovary syndrome?. J Clin Endocrinol Metab 2010, 95(2):810-819.
35. Barber T.M., Wass J.A., McCarthy M.I., Franks S. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2007, 66(4):513-517.
36. Munro C.J., Stabenfeldt G.H., Cragun J.R., Addiego L.A., Overstreet J.W., Lasley B.L. Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay. Clin Chem 1991, 37(6):838-844.
37. Miller R.C., Brindle E., Holman D.J., Shofer J., Klein N.A., Soules M.R., et al. Comparison of specific gravity and creatinine for normalizing urinary reproductive hormone concentrations. Clin Chem 2004, 50(5):924-932.
38. Misra M., Prabhakaran R., Miller K.K., Goldstein M.A., Mickley D., Clauss L., et al. Prognostic indicators of changes in bone density measures in adolescent girls with anorexia nervosa-II. J Clin Endocrinol Metab 2008, 93(4):1292-1297.
39. Wong I.P., Baldock P.A., Herzog H. Gastrointestinal peptides and bone health. Curr Opin Endocrinol Diabetes Obes 2010, 17(1):44-50.
40. Baldock P.A., Sainsbury A., Couzens M., Enriquez R.F., Thomas G.P., Gardiner E.M., et al. Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 2002, 109(7):915-921.
41. Wortley K.E., Garcia K., Okamoto H., Thabet K., Anderson K.D., Shen V., et al. Peptide YY regulates bone turnover in rodents. Gastroenterology 2007, 133(5):1534-1543.
42. Jacobson-Dickman E., Misra M. Skeletal abnormalities in anorexia nervosa. IBMS BoneKEy 2010, 7(2):63-83.
43. Miller K.K., Lee E.E., Lawson E.A., Misra M., Minihan J., Grinspoon S.K., et al. Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab 2006, 91(8):2931-2937.
44. Legroux-Gerot I., Vignau J., D'Herbomez M., Collier F., Marchandise X., Duquesnoy B., et al. Evaluation of bone loss and its mechanisms in anorexia nervosa. Calcif Tissue Int 2007, 81(3):174-182.
45. Grinspoon S., Miller K., Coyle C., Krempin J., Armstrong C., Pitts S., et al. Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab 1999, 84(6):2049-2055.
46. Miller K.K., Grinspoon S., Gleysteen S., Grieco K.A., Ciampa J., Breu J., et al. Preservation of neuroendocrine control of reproductive function despite severe undernutrition. J Clin Endocrinol Metab 2004, 89(9):4434.
47. Grinspoon S., Thomas E., Pitts S., Gross E., Mickley D., Miller K., et al. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med 2000, 133(10):790-794.
48. Drinkwater B.L., Nilson K., Ott S., Chesnut C.H. Bone mineral density after resumption of menses in amenorrheic athletes. JAMA 1986, 256(3):380-382.
49. Stock S., Leichner P., Wong A.C., Ghatei M.A., Kieffer T.J., Bloom S.R., et al. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab 2005, 90(4):2161-2168.
50. Yakar S., Rosen C.J., Beamer W.G., Ackert-Bicknell C.L., Wu Y., Liu J.L., et al. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 2002, 110(6):771-781.